Form 4: Surgery Partners Executive Marissa Brittenham Receives Stock Awards

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., reports the acquisition of restricted stock awards.

Summary

• Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., filed a Form 4 on March 6, 2025, reporting changes in beneficial ownership.
• On March 4, 2025, Ms. Brittenham acquired 10,084 restricted stock awards (RSAs) at a price of $23.80, which vest in three equal annual installments beginning on the first anniversary of the grant date.
• Additionally, she acquired 6,302 RSAs at the same price of $23.80, which vest on the first anniversary of the grant date.
• Following these transactions, Ms. Brittenham beneficially owns 66,564 shares of Surgery Partners, Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction of stock awards to an executive. It's neither overwhelmingly positive nor negative.

Positives

• The acquisition of restricted stock awards by a key executive can be seen as a positive sign, aligning the executive's interests with the company's long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The stock awards may incentivize the executive to work towards increasing shareholder value.

Key Dates

Keywords

Surgery Partners, SGRY, Form 4, Beneficial Ownership, Restricted Stock Awards, Marissa Brittenham, Chief Strategy Officer